Neurotoxic effects of ecstasy on the thalamus

Br J Psychiatry. 2008 Oct;193(4):289-96. doi: 10.1192/bjp.bp.106.035089.

Abstract

Background: Neurotoxic effects of ecstasy have been reported, although it remains unclear whether effects can be attributed to ecstasy, other recreational drugs or a combination of these.

Aims: To assess specific/independent neurotoxic effects of heavy ecstasy use and contributions of amphetamine, cocaine and cannabis as part of The Netherlands XTC Toxicity (NeXT) study.

Method: Effects of ecstasy and other substances were assessed with (1)H-magnetic resonance spectroscopy, diffusion tensor imaging, perfusion weighted imaging and [(123)I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane ([(123)I]beta-CIT) single photon emission computed tomography (serotonin transporters) in a sample (n=71) with broad variation in drug use, using multiple regression analyses.

Results: Ecstasy showed specific effects in the thalamus with decreased [(123)I]beta-CIT binding, suggesting serotonergic axonal damage; decreased fractional anisotropy, suggesting axonal loss; and increased cerebral blood volume probably caused by serotonin depletion. Ecstasy had no effect on brain metabolites and apparent diffusion coefficients.

Conclusions: Converging evidence was found for a specific toxic effect of ecstasy on serotonergic axons in the thalamus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Amphetamine-Related Disorders / complications*
  • Amphetamine-Related Disorders / diagnostic imaging
  • Cross-Sectional Studies
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Neurotoxicity Syndromes / etiology*
  • Serotonin Agents / adverse effects*
  • Thalamic Diseases / chemically induced*
  • Thalamic Diseases / diagnostic imaging
  • Thalamus / drug effects*
  • Tomography, Emission-Computed, Single-Photon
  • Young Adult

Substances

  • Serotonin Agents
  • N-Methyl-3,4-methylenedioxyamphetamine